Farmacias Benavides, S.A.B. de C.V.
FBNVF
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 238.04M | 218.59M | 219.23M | 254.40M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 238.04M | 218.59M | 219.23M | 254.40M | |
| Cost of Revenue | 164.82M | 148.83M | 153.72M | 175.79M | |
| Gross Profit | 73.22M | 69.76M | 65.50M | 78.61M | |
| SG&A Expenses | 61.03M | 58.59M | 94.64M | 66.06M | |
| Depreciation & Amortization | -- | -- | -39.75M | -- | |
| Other Operating Expenses | -1.41M | -1.12M | 2.15M | -424.80K | |
| Total Operating Expenses | 224.45M | 206.30M | 210.76M | 241.43M | |
| Operating Income | 13.60M | 12.29M | 8.47M | 12.97M | |
| Income Before Tax | 7.43M | 5.95M | 2.56M | 5.87M | |
| Income Tax Expenses | 2.38M | 1.50M | 7.27M | 1.97M | |
| Earnings from Continuing Operations | 5.05M | 4.45M | -4.71M | 3.91M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 5.05M | 4.45M | -4.71M | 3.91M | |
| EBIT | 13.60M | 12.29M | 8.47M | 12.97M | |
| EBITDA | 26.89M | 25.06M | 11.62M | 30.51M | |
| EPS Basic | 0.01 | 0.01 | -0.01 | 0.01 | |
| Normalized Basic EPS | 0.01 | 0.01 | 0.00 | 0.01 | |
| EPS Diluted | 0.01 | 0.01 | -0.01 | 0.01 | |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.00 | 0.01 | |
| Average Basic Shares Outstanding | 409.03M | 408.84M | 408.84M | 408.01M | |
| Average Diluted Shares Outstanding | 409.03M | 408.84M | 408.84M | 408.01M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |